NDC 17163-015 - API General Cure
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 17163-015
- Package NDCs from labels
- 17163-015-16
- Manufacturer
- MARS FISHCARE NORTH AMERICA, INC. | Alivira Animal Health Limited
- Effective date
- 2022-04-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PRAZIQUANTEL - MARS FISHCARE NORTH AMERICA, INC. | Alivira Animal Health Limited | MARS FISHCARE NORTH AMERICA, INC. | Alivira Animal Health Limited | 2022-04-19 | OTC ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17163-015-16 | API General Cure | 2 g in 1 PACKET | POWDER | 2 | 6 | |
| 17163-015-16 | API General Cure | 10 in 1 BOX | POWDER | 10 | 6 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Metronidazole | METRONIDAZOLE | Cosette Pharmaceuticals, Inc. | de4cb39f-cc6e-98fb-05e5-103f3aca2dad | 2023-11-29 | Adverse reactions | 140QMO216E |
| Nuvessa | METRONIDAZOLE | Exeltis USA, Inc. | 3b6ff39d-f84b-43b3-9b07-c0521c6d7968 | 2023-11-10 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | A-S Medication Solutions | 8b2c294b-ed70-447c-bbc4-2a8b59f1aca4 | 2023-10-25 | Warnings, Adverse reactions | 140QMO216E |
| metronidazole vaginal | METRONIDAZOLE | Padagis Israel Pharmaceuticals Ltd | eb240e7b-cec8-497b-8a49-7ed768e2b431 | 2023-07-25 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Cosette Pharmaceuticals, Inc. | d76810d5-11b4-4b5e-b850-230f59376c34 | 2023-07-18 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Zydus Lifesciences Limited | 728ebe6d-7a20-481d-845a-ceffa450179f | 2023-05-05 | 140QMO216E | |
| Metronidazole | METRONIDAZOLE | A-S Medication Solutions | bff2f5bd-75a4-4252-a643-c21741ae8a96 | 2023-02-06 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Cosette Pharmaceuticals, Inc. | a0d7d4e8-28c0-4211-8d76-73a173b48d9a | 2023-01-31 | Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Alembic Pharmaceuticals Limited | 80c79325-1ea4-46f8-b9b8-967b7640c51d | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Alembic Pharmaceuticals Limited | d7455566-16aa-488a-af2a-93b55a04c02f | 2023-01-30 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Alembic Pharmaceuticals Limited | 387053e5-7eda-4282-b58a-5789430a2e99 | 2023-01-27 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Proficient Rx LP | 205054e1-8172-47dc-931c-a18a60e7e9f0 | 2022-12-01 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Cosette Pharmaceuticals, Inc. | 86da8d86-5ab2-f668-fdfd-b0e93e6a2245 | 2022-11-21 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | PharmPak, Inc. | be23affb-5b30-40ee-b0b5-829666bafaeb | 2022-10-09 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | PharmPak, Inc. | 6a77b5b6-3199-4526-bd68-2e511353d7c6 | 2022-10-09 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Alembic Labs LLC | 86415209-5440-41da-abb8-e1a3d5051f91 | 2022-06-24 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | Oceanside Pharmaceuticals | cdf2e251-4bbc-4434-9b00-bef6284491e4 | 2022-06-21 | Adverse reactions | 140QMO216E |
| Metronidazole | METRONIDAZOLE | AvPAK | 9623181f-5e3b-3695-e053-2a95a90a99f6 | 2022-05-06 | Boxed warning, Warnings, Adverse reactions | 140QMO216E |
| Noritate | METRONIDAZOLE | Bausch Health US, LLC | 706b09da-6cf9-421d-8e91-f3999474d322 | 2020-06-01 | Adverse reactions | 140QMO216E |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.